Clinical Trial Update: Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 study assessing tumor response to cetuximab in head and neck squamous cell carcinoma using FDG-PET/CT before and after treatment; results posted in 2015…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Squamous Cell Carcinoma

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Carcinoma, Squamous Cell | Phase 2 | Status: COMPLETED | Results posted: 2015-08-10